GENERALIZED LIPODYSTROPHY

Clinical trials for GENERALIZED LIPODYSTROPHY explained in plain language.

Never miss a new study

Get alerted when new GENERALIZED LIPODYSTROPHY trials appear

Sign up with your email to follow new studies for GENERALIZED LIPODYSTROPHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1 Completed 3 Terminated 1

Lifesaving drug made available for rare fat disorder patients

Disease control Ongoing

This study gives the drug metreleptin to people with generalized lipodystrophy, a rare condition that causes severe fat loss and leads to high blood fats and diabetes. Participants, aged 6 months and older, have already received metreleptin in past NIH studies but cannot get it i…

Matched conditions: GENERALIZED LIPODYSTROPHY

Phase: PHASE3 • Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Disease control

Last updated Jul 19, 2026 00:00 UTC

GENERALIZED LIPODYSTROPHY

Get alerted when new GENERALIZED LIPODYSTROPHY trials appear

Lifesaving drug made available for rare fat disorder patients